AOMs result in 8% relative risk reduction in any CVD events in patients with obesity
The utilisation of anti-obesity medications (AOMs) among people with obesity could potentially alleviate the high prevalence of...
top of page
Browse by category
Search
Factors associated with long-term use of FDA-approved anti-obesity medications
Only 19% of the patients continued to use the anti-obesity medications (AOMs) one year after their initial prescriptions and patients...
Browse by tag
bottom of page